Menthol’s back on the cap table. Juul’s path to relevance gets reopened, one pod at a time.

After teetering on the edge of bankruptcy for the better part of two years, Juul Labs has pulled off the nicotine industry’s equivalent of a plot twist: the FDA has authorized the company to resume selling its menthol-flavored e-cigarettes.

The decision doesn’t clear Juul of controversy, lawsuits, or long-term scrutiny—but it does give them a path forward that doesn’t include liquidation sales or trading office furniture for legal counsel.

Menthol is now the comeback flavor of the decade, after years of regulatory purgatory for Juul. The company had faced a sweeping ban in 2022, only to claw its way back through court battles and bureaucratic limbo, finally winning the right to legally sell one product again. Not new, not rebranded—just the same menthol pods they were almost banned over.

This isn't quite a victory lap.

More like a very cautious walk back onto the racetrack with a clipboard and an FDA minder watching every step.

Still, for a company once pegged as the poster child for youth vaping addiction—and nearly erased by regulators—it’s a remarkable turnaround. The cash crunch was real. So were the layoffs. And now? A quiet, regulation-approved exhale.

Disclaimer: This content is for informational and entertainment purposes only and does not constitute financial or investment advice. The information provided may be outdated or contain inaccuracies. Always conduct your own due diligence and consult a licensed financial advisor before making investment decisions. Investing involves risk, including the potential loss of principal. Unless explicitly stated otherwise, neither Equiscreen, LLC nor its beneficial owners hold any financial interest in the companies mentioned in our articles, and we do not receive compensation for including them. Equiscreen, LLC and its beneficial owners may buy or sell securities of any company referenced in our content at any time and without prior notice, and nothing published by Equiscreen, LLC should be interpreted as a recommendation to buy, sell, or hold any security. Any paid content or income-related materials will be clearly identified as “Sponsored” or “Advertorial,” and corresponding income disclosures can be found at the bottom of the page. For additional information, please contact [email protected].

Top Gainers

Top Losers

U.S. Commodities

2234 N Federal Hwy # 1022
Boca Raton, FL 33431

(561) 264-5726